Journal article

SERUM LEVELS OF INTERLEUKIN-10 IN PATIENTS WITH DIFFUSE LARGE-CELL LYMPHOMA - LACK OF CORRELATION WITH PROGNOSIS

JE CORTES, M TALPAZ, F CABANILLAS, JF SEYMOUR, R KURZROCK

BLOOD | W B SAUNDERS CO | Published : 1995

Abstract

Interleukin-10 (IL-10), also known as cytokine synthesis inhibitory factor, has multiple effects on lymphoid development. In addition, it has been previously reported that serum levels of IL-10 correlate with failure-free and overall survival in patients with non-Hodgkin's lymphoma. In this study, we used a sensitive enzyme-linked immunosorbent assay specific for human IL-10 (lower limit of sensitivity, 5 pg/mL) to measure serum levels in 52 newly diagnosed patients with diffuse large cell lymphoma and at least one adverse prognostic feature who were subsequently treated in a uniform way. Lymphoma patients had significantly higher serum levels of IL-10 (median, 7.98 pg/mL; range, < or = 5 to..

View full abstract